David Jin
Overview
David Jin received $260K in total compensation at AVENUE THERAPEUTICS in 2023. David Jin also received an average of $1M at Fortress Biotech between 2022 and 2023 and an average of $512K at Avalon GloboCare Corp. from 2017 to 2023.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
Related executives
We found 14 more executives who work or worked at AVENUE THERAPEUTICS, Fortress Biotech, andAvalon GloboCare Corp..
Alexandra MacLean
AVENUE THERAPEUTICS
Chief Executive Officer
Lindsay Rosenwald
Fortress Biotech
Chief Executive Officer
Michael Weiss
Fortress Biotech
Chairman
Luisa Ingargiola
Avalon GloboCare Corp.
Chief Financial Officer
Meng Li
Avalon GloboCare Corp.
Chief Operating Officer
Lucy Lu
AVENUE THERAPEUTICS
Chief Executive Officer
Joseph Vazzano
AVENUE THERAPEUTICS
Chief Financial Officer
Yu Zhou
Avalon GloboCare Corp.
Chief Executive Officer
News
August 28, 2024
May 3, 2024
April 5, 2024
September 8, 2023
November 21, 2022
December 13, 2021
June 22, 2020
June 17, 2019